HIGHFDA DEVICE

Sophysa Recalls Pressio 2 ICP Monitoring System Due to Rebooting Hazard

Sophysa recalled 105 units of the Pressio 2 ICP Monitoring System on November 17, 2025, after receiving customer complaints regarding unexpected rebooting. This defect poses a high risk for patients relying on the device for monitoring intracranial pressure. Users should stop using the device immediately and follow the manufacturer's instructions.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
November 17, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
November 17, 2025
Hazard Level
HIGH
Brand
Sophysa
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Sophysa
Product type
Intracranial Pressure Monitor
Model numbers
PSO-4000, UDI/DI 03760124132076
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    November 17, 2025

  2. Reported by FDA DEVICE

    January 14, 2026

  3. RecallRadar source check

    January 21, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Customer complaints of Pressio monitor rebooting.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Sophysa or your healthcare provider for instructions

About This Product

The Pressio 2 ICP Monitoring System is designed for monitoring intracranial pressure in patients, primarily used in hospitals and clinical settings. It is critical for managing patients with conditions affecting brain pressure.

Why This Is Dangerous

The rebooting issue in the Pressio monitor can cause loss of monitoring capabilities, potentially compromising patient safety. This defect may lead to delayed responses in critical situations.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients and healthcare providers need to act quickly to prevent risks associated with the monitor's malfunction. The urgency is high, as improper monitoring can have severe health implications.

Practical Guidance

How to identify if yours is affected

  1. Check the model number on the back of the device.
  2. Ensure your model is PSO-4000 to confirm if it is affected.
  3. Look for any recent complaints or notices from your healthcare provider regarding this device.

Where to find product info

The model number can typically be found on the device's label or in the user manual.

What timeline to expect

Expect a response for refunds or replacements within 4-6 weeks after contacting Sophysa.

If the manufacturer is unresponsive

  • Document all communication attempts with the manufacturer.
  • Reach out to your healthcare provider for assistance.
  • Consider reporting the issue to the FDA if unresolved.

How to prevent similar issues

  • When purchasing medical devices, ensure they have thorough reviews and safety certifications.
  • Stay updated on recalls by subscribing to health safety bulletins.
  • Discuss any concerns regarding medical devices with healthcare professionals before use.

Documentation advice

Keep records of all communications with the manufacturer, including emails, phone calls, and any receipts related to the purchase.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The Pressio 2 ICP Monitoring System, Model Number PSO-4000, is designed for monitoring intracranial pressure. It was distributed nationwide in states including Arizona, Wisconsin, Texas, Oregon, California, Oklahoma, Idaho, Florida, and New Jersey.

Key Facts

  • Rebooting issue poses health risks
  • Distributed in multiple U.S. states
  • Immediate discontinuation of use recommended

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeIntracranial Pressure Monitor
Sold At
Multiple Retailers

Product Details

Brand
Model Numbers
PSO-4000
UDI/DI 03760124132076
Affected States
ALL
Report Date
January 14, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more